Covid-19 spike proteins linger in the brain for years: Study
Scientists discover that SARS-CoV-2 spike protein remains in the brain and skull bone marrow for years post-infection, causing chronic inflammation and increasing neurodegenerative disease risk. The BioNTech/Pfizer mRNA vaccine reduces spike protein levels, but residual levels persist, necessitating additional treatments for Long COVID neurological symptoms.
Scientists discover that SARS-CoV-2 spike protein remains in the brain and skull bone marrow for years post-infection, causing chronic inflammation and increasing neurodegenerative disease risk. The BioNTech/Pfizer mRNA vaccine reduces spike protein levels, but residual levels persist, necessitating additional treatments for Long COVID neurological symptoms.
